Rebecca Chambers is Chief Financial Officer of VERACYTE, INC.. Currently has a direct ownership of 109,496 shares of VCYT, which is worth approximately $4.31 Million. The most recent transaction as insider was on Sep 02, 2022, when has been sold 3,023 shares (Common Stock) at a price of $19.18 per share, resulting in proceeds of $57,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K
17.77% 3M change
3.98% 12M change
Total Value Held $4.31 Million

Rebecca Chambers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 02 2022
SELL
Payment of exercise price or tax liability
$57,981 $19.18 p/Share
3,023 Reduced 3.94%
73,733 Common Stock
Aug 05 2022
BUY
Grant, award, or other acquisition
-
21,404 Added 21.81%
76,756 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
20,728 Added 27.47%
54,728 Common Stock
Jul 19 2021
BUY
Grant, award, or other acquisition
-
34,000 Added 50.0%
34,000 Common Stock

Also insider at

NARI
Inari Medical, Inc. Healthcare
OM
Outset Medical, Inc. Healthcare
RC

Rebecca Chambers

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on VCYT

Follow VERACYTE, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCYT shares.

Notify only if

Insider Trading

Get notified when an Veracyte, Inc. insider buys or sells VCYT shares.

Notify only if

News

Receive news related to VERACYTE, INC.

Track Activities on VCYT